Public Inspection: CMS: Charter Amendments, Establishments, Renewals and Terminations: Establishment of the Medicare Drug Rebate and Negotiations Group within the Center for Medicare

Pre-publication notice from the Centers for Medicare& Medicaid Services (CMS) establishing the Medicare Drug Rebate and Negotiations Group within the Center for Medicare to implement the Drug Price Negotiation Program and the Inflation Rebate Program in Medicare Part B and Part D as authorized under the Inflation Reduction Act of 2022. The Drug Price Negotiation Program group will negotiate drug prices with pharmaceutical manufacturers for certain Part B and Part D drugs, and the Inflation Rebate Program will determine which drugs had price increases exceeding inflation and compute, invoice, and collect rebates owed by manufacturers. This reorganization is effective October 8, 2022.
Source: Federal Register updates via the Rural Assistance Center - Category: Rural Health Source Type: news